T2 Biosystems, Inc.·4

Nov 28, 4:05 PM ET

Giffin Brett A. 4

4 · T2 Biosystems, Inc. · Filed Nov 28, 2023

Insider Transaction Report

Form 4
Period: 2023-11-08
Giffin Brett A.
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-11-08+3364 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-11-083334 total
    Common Stock (33 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On February 26, 2022 the reporting person was granted 100 RSU's that vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4